Trocoxil, generic name mavacoxib, is one of the newer forms of NSAIDs. The drug belongs to the COXIB class, which means it selectively inhibits only COX enzymes, which contribute to the development of inflammation. In September 2008, the European Commission allowed the drug to be sold in EU member nations as the Committee for Medicinal Products for Veterinary Use (CVMP) reached to a conclusion that Trocoxil’s benefits exceeded the risks for the treatment of dog arthritis symptoms.
Read More…


